Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Int J Immunopathol Pharmacol ; 21(3): 751-6, 2008.
Article in English | MEDLINE | ID: mdl-18831914

ABSTRACT

Cryptococcus neoformans infections are typically associated with T-cell deficiencies, including acquired immunodeficiency syndrome (AIDS). Although highly active antiretroviral therapy (HAART) has strongly reduced AIDS-related opportunistic infections, the restoration and reactivation of CD4+ cells can induce an immune reconstitution inflammatory syndrome (IRIS), consisting in a deregulated inflammatory response to latent infectious pathogens and/or to their residual antigens. Cryptococcal lymphadenitis has occasionally been documented in IRIS. Here we report a case of histology- and culture-negative cryptococcal lymphadenitis associated with IRIS in an adult AIDS patient with a history of disseminated cryptococcosis, after the start of fully adherent HAART. Appropriate diagnosis was established on nested-PCR and sequence analysis of the interspacer region 2 of C. neoformans ribosomal DNA, and detection of slow-growing blastospores in enrichment cultures of fine-needle lymph node aspirate. Review of recent literature and our case findings suggest that IRIS-associated cryptococcal lymphadenitis is more likely the flare up of a latent infection rather than an immunopathological response to residual antigen of unviable cryptococci.


Subject(s)
AIDS-Related Opportunistic Infections/etiology , Cryptococcosis/etiology , HIV Seropositivity/complications , Inflammation/complications , Lymphadenitis/etiology , Adult , Humans , Male , Syndrome
2.
Plant Physiol Biochem ; 44(10): 604-10, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17056265

ABSTRACT

A 23-kDa antifungal thaumatin-like protein was isolated and purified from Cassia didymobotrya (Fres.) cell cultures for the first time. The protein was secreted in the culture medium, but it could be also isolated after elution of whole cells with a 0.5 M CaCl(2) solution. Treatment of the cells with laminarin oligosaccharides or salicylic acid, but not with NaCl, resulted in enhancement of expression of the protein. A rapid purification protocol was used based on cationic exchange chromatography. The protein, with a highly basic character (pI 10), has an exact molecular mass of 23034 Da, as determined by MALDI-ToF mass spectrometry analysis. N-terminal sequencing of the intact polypeptide and the sequencing of two internal tryptic peptides indicated significant identity with other thaumatin-like proteins (TLP). The protein exerted antifungal activity towards some Candida species showing EC(50) values comparable to those of other antifungal TLPs. The collected data lead to classify this TLP as a new PR-5 protein.


Subject(s)
Antifungal Agents/metabolism , Cassia/metabolism , Plant Proteins/metabolism , Amino Acid Sequence , Cells, Cultured , Gene Expression Regulation, Plant , Molecular Sequence Data
3.
Int J Tuberc Lung Dis ; 10(2): 146-52, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16499252

ABSTRACT

SETTING: Division of respiratory medicine in a specialised infectious disease hospital in Rome, Italy. OBJECTIVE: Retrospective evaluation of tuberculosis (TB) care associated costs in an integrated in- and out-patient management programme. DESIGN: Review of the medical records of 92 human immunodeficiency virus negative TB cases admitted between September 2000 and May 2003. RESULTS: Length of in-hospital stay (45 +/- 35 days) was the major cost determinant, as hospitalisation accounted for almost 80% of the total costs of the case, with fixed bed-per-day charges amounting to 76% of hospital costs. Factors associated with higher costs were chest X-ray score, fever, sputum bacterial load and multidrug resistance (P < 0.05). Cure/treatment completion was achieved in 82% of patients entering the out-patient programme (63% of all cases). Homelessness, age and comorbidities were associated with unfavourable outcomes. CONCLUSIONS: A closely followed hospital-centred protocol carried out in a high-resource setting may produce acceptable cure/completion treatment rates. As a too high fraction of resources invested in TB control goes toward hospital costs, out-patient treatment strategies should be implemented.


Subject(s)
Antitubercular Agents/therapeutic use , Health Care Costs , Hospitalization/economics , Outcome Assessment, Health Care/economics , Tuberculosis/therapy , Adult , Aged , Antitubercular Agents/economics , Female , Humans , Italy/epidemiology , Male , Middle Aged , Prevalence , Retrospective Studies , Tuberculosis/epidemiology
4.
Clin Microbiol Infect ; 10(4): 332-4, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15059123

ABSTRACT

The BDProbeTec MTB assay for direct detection of Mycobacterium tuberculosis was evaluated in comparison with the AMTD-II assay on 94 samples from different patients with clinical suspicion of tuberculosis. Using a combination of culture on Lowenstein-Jensen medium (with or without preculture in BACTEC 9000) and clinical diagnosis as the standard, BDProbeTec MTB showed high sensitivity and specificity (96.1% and 100%, respectively), similar to AMTD-II (96.1% and 97.1%, respectively), with significantly higher sensitivity than the Ziehl-Neelsen stain for acid-fast bacilli (73%, p < 0.05).


Subject(s)
Mycobacterium tuberculosis/isolation & purification , Nucleic Acid Amplification Techniques/methods , Tuberculosis, Pulmonary/diagnosis , Tuberculosis/diagnosis , Culture Media , DNA Transposable Elements/genetics , DNA, Ribosomal/genetics , Humans , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/growth & development , RNA, Ribosomal, 16S/genetics , Reagent Kits, Diagnostic , Sensitivity and Specificity , Tuberculosis/microbiology , Tuberculosis, Pulmonary/microbiology
5.
Emerg Infect Dis ; 7(6): 1032-5, 2001.
Article in English | MEDLINE | ID: mdl-11747736

ABSTRACT

We describe the first case of community-acquired bacteremia caused by Acinetobacter radioresistens; the patient was a 32-year-old HIV-positive neutropenic woman. Ambiguous Gram staining and poor biochemical reactivity of blood culture isolates misguided early diagnosis and therapy. Bacterial identification was based on 16S rDNA sequence analysis. A. radioresistens can be considered as a cause of opportunistic infection in immunodeficient patients.


Subject(s)
AIDS-Related Opportunistic Infections/microbiology , Acinetobacter Infections/microbiology , Acinetobacter/isolation & purification , Bacteremia/microbiology , Community-Acquired Infections/microbiology , Neutropenia/microbiology , AIDS-Related Opportunistic Infections/diagnosis , AIDS-Related Opportunistic Infections/drug therapy , AIDS-Related Opportunistic Infections/physiopathology , Acinetobacter/classification , Acinetobacter/genetics , Acinetobacter Infections/diagnosis , Acinetobacter Infections/drug therapy , Acinetobacter Infections/physiopathology , Adult , Anti-Infective Agents/therapeutic use , Bacteremia/diagnosis , Bacteremia/drug therapy , Bacteremia/physiopathology , Ciprofloxacin/therapeutic use , Community-Acquired Infections/diagnosis , Community-Acquired Infections/drug therapy , Community-Acquired Infections/physiopathology , Female , Humans , Italy , Neutropenia/complications , Neutropenia/physiopathology , RNA, Bacterial/analysis , RNA, Ribosomal, 16S/analysis , Retrospective Studies , Treatment Outcome
6.
Infection ; 27(6): 331-4, 1999.
Article in English | MEDLINE | ID: mdl-10624592

ABSTRACT

We performed a retrospective study based on chart review of 118 HIV-infected patients with culture-confirmed pulmonary TB, in which M. tuberculosis isolates were tested for drug susceptibility. Patients were enrolled in the period January 1987 to December 1996 and followed until September 1997. The median survival for the entire cohort was 15.2 months with a 1-year survival rate of 57%. Prior AIDS-defining illness, low CD4 count (< 200/mm3), not having received antituberculous therapy with at least two drugs to which M. tuberculosis was susceptible in vitro, starting within four weeks of diagnosis, treatment duration of less than three weeks and multidrug resistant tuberculosis were each independently associated with decreased survival in multivariate analysis.


Subject(s)
Acquired Immunodeficiency Syndrome/microbiology , Acquired Immunodeficiency Syndrome/mortality , HIV Infections/microbiology , HIV Infections/mortality , Tuberculosis, Pulmonary/diagnosis , AIDS-Related Opportunistic Infections/diagnosis , AIDS-Related Opportunistic Infections/drug therapy , AIDS-Related Opportunistic Infections/mortality , Acquired Immunodeficiency Syndrome/immunology , Adult , Antibiotics, Antitubercular/pharmacology , Antibiotics, Antitubercular/therapeutic use , Antitubercular Agents/pharmacology , Antitubercular Agents/therapeutic use , CD4 Lymphocyte Count , Drug Resistance, Microbial , Drug Resistance, Multiple , Female , HIV Infections/immunology , Humans , Isoniazid/pharmacology , Isoniazid/therapeutic use , Longitudinal Studies , Male , Mycobacterium tuberculosis/drug effects , Prognosis , Retrospective Studies , Rifampin/pharmacology , Rifampin/therapeutic use , Risk Factors , Time Factors , Tuberculosis, Pulmonary/drug therapy
7.
Minerva Med ; 89(5): 173-5, 1998 May.
Article in English | MEDLINE | ID: mdl-9676183

ABSTRACT

Several reports have showed Cryptosporidium species as a cause of intractable diarrhea and malabsorption in patients with acquired immunodeficiency syndrome (HIV). A case of chronic diarrhea in a drug addict woman associated with a symptomatic interstitial pulmonary infection due to Cryptosporidium parvum is described. This unusual C. parvum spread into the bronchial tree is underlined and a survey of the literature is made.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Cryptosporidiosis/diagnosis , Cryptosporidium parvum , Lung Diseases, Parasitic/diagnosis , Adult , Albendazole/therapeutic use , Animals , Anthelmintics/therapeutic use , Bronchoalveolar Lavage Fluid , Cryptosporidiosis/drug therapy , Cryptosporidium parvum/isolation & purification , Feces/parasitology , Female , Humans , Lung Diseases, Parasitic/drug therapy , Radiography, Thoracic , Sputum/parasitology , Substance-Related Disorders/complications
8.
J Chemother ; 2(2): 100-7, 1990 Apr.
Article in English | MEDLINE | ID: mdl-2193998

ABSTRACT

We have assessed the efficacy and safety of imipenem/cilastatin in a non-comparative study of 27 immunocompromised patients suffering from severe bacterial infections. Moreover in two groups of 14 patients the efficacy of imipenem/cilastatin versus a standard broad spectrum antibiotic therapy has also been compared. Clinical and microbiological efficacy and side effects have been evaluated.


Subject(s)
Bacterial Infections/drug therapy , Cilastatin/therapeutic use , Imipenem/therapeutic use , Adolescent , Adult , Aged , Cilastatin/adverse effects , Drug Synergism , Drug Therapy, Combination , Endocarditis, Bacterial/drug therapy , Female , Humans , Imipenem/adverse effects , Male , Middle Aged , Prospective Studies , Randomized Controlled Trials as Topic , Urinary Tract Infections/drug therapy , Urinary Tract Infections/microbiology
10.
Ann Sclavo ; 18(2): 165-74, 1976.
Article in Italian | MEDLINE | ID: mdl-13743

ABSTRACT

The routine bacteriological test of expectorate, except for mycobacteria, is usually unsatisfactory. There is a need of standardization which results in the present paper from a comparison between the data obtained by two different laboratories on the same samples. It is possible to achieve reasonable and uniform results establishing a uniformity of some procedures, namely; collection of specimens, homogenization, number and type of media, interpretation of data and so on.


Subject(s)
Sputum/microbiology , Aerobiosis , Escherichia coli/isolation & purification , Haemophilus/isolation & purification , Humans , Klebsiella/isolation & purification , Methods , Neisseria/isolation & purification , Proteus/isolation & purification , Pseudomonas/isolation & purification , Respiratory System/microbiology , Staphylococcus/isolation & purification , Streptococcus/isolation & purification , Streptococcus pneumoniae/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...